Press Release

Security of supply during the coronavirus crisis: ABF Pharmaceutical Services classified as "critical infrastructure" by the Federal Chancellery

"The classification of our company as a ‘critical infrastructure’ is very important for our business partners in the pharmaceutical and biotech industry as well as for patients and doctors, especially during the current coronavirus crisis. This is because the classification ensures that our operations can continue even in the event of a complete shutdown of the economy and that we thus would be able to continue to fulfill our mandate to supply drugs critical to human health," said Dr Elisabeth Lackner, Chief Executive Officer of ABF Pharmaceutical Services and GBA Group Pharma.

Corona-News **

Please find latest news down below.**

In the light of the dynamic circumstances around the Coronavirus, LKF would like to reassure you that we are constantly monitoring the situation with the goal of maintaining uninterrupted shipments of our supplies to your clinical sites as well as biological specimens to LKF, while also protecting the health of our employees.

Dear Customers! In view of the fact that the general conditions, in the wake of the Corona crisis, are changing constantly, and at short notice, we would like to take this opportunity to inform you regularly about the status of the GBA GROUP PHARMA. Currently, all our locations are fully operational and efficient with sufficient capacities to be able to react to your needs at short notice.

To our valued customers,

We at ABF want you to know that we are committed to you. We are closely monitoring the pandemic, following guidance and advice from the World Health Organization (WHO) and local health organizations.

Press Release

Kiel and Hamburg, Germany, and Vienna, Austria, 06 March 2020 - LKF - Laboratorium für Klinische Forschung GmbH, a subsidiary of GBA Group Pharma, is honouring International Women's Day on 8 March 2020 by highlighting the company's female success factors.

"Every day is Women's Day at LKF," says Bärbel Wilke, co-founder and CEO of LKF, with 80 percent of its 150 employees being women. Many of the 120 female employees working in the three-storey laboratory are highly qualified specialists and scientists from the fields of chemistry, biology, molecular biology et al.